Atea Pharmaceuticals, Inc. Increase (Decrease) in Other Operating Assets
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-12
- Atea Pharmaceuticals, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $0.00.
- Atea Pharmaceuticals, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was -$88.00K, a 102.10% decline year-over-year.
- Atea Pharmaceuticals, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$2.34M.
- Atea Pharmaceuticals, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $1.08M.
- Atea Pharmaceuticals, Inc. increase (decrease) in other operating assets for fiscal 2025 was $2.94M.
- Atea Pharmaceuticals, Inc. increase (decrease) in other operating assets for fiscal 2024 was $0.00.
- Atea Pharmaceuticals, Inc. increase (decrease) in other operating assets for fiscal 2023 was -$98.00K, a 106.56% decline from fiscal 2022.
- Atea Pharmaceuticals, Inc. increase (decrease) in other operating assets for fiscal 2022 was $1.49M, a 827.95% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$88.00K 10-Q · filed 2026-08-12 | -$2.43M derived: sum of 3 quarters · filed 2026-08-12 | -$1.35M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$88.00K 10-Q · filed 2026-05-12 | -$2.43M derived: sum of 2 quarters · filed 2026-05-12 | -$1.35M derived: sum of 3 quarters · filed 2026-05-12 | -$1.35M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$1.26M derived: sum of 2 quarters · filed 2026-03-05 | -$1.26M derived: sum of 3 quarters · filed 2026-08-12 | $2.94M 10-K · filed 2026-03-05 |
| 2025-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.08M derived: sum of 2 quarters · filed 2026-08-12 | $5.28M 10-Q · filed 2025-11-12 | $4.99M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $4.20M 10-Q · filed 2026-08-12 | $3.91M derived: sum of 3 quarters · filed 2026-08-12 | |
| 2025-03-31 | $4.20M 10-Q · filed 2026-05-12 | $3.91M derived: sum of 2 quarters · filed 2026-05-12 | ||
| 2024-12-31 | -$287.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 10-K · filed 2026-03-05 | ||
| 2024-09-30 | $287.00K 10-Q · filed 2025-11-12 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | -$295.00K derived: sum of 3 quarters · filed 2025-03-06 | -$98.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$295.00K derived: sum of 2 quarters · filed 2024-11-07 | -$98.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$295.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$98.00K 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $197.00K 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | $1.49M 10-K · filed 2024-02-28 | |||
| 2021-12-31 | -$66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$132.00K derived: sum of 2 quarters · filed 2023-02-28 | -$195.00K derived: sum of 3 quarters · filed 2023-02-28 | $161.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | -$66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$129.00K derived: sum of 2 quarters · filed 2022-11-07 | $227.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $293.00K 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $356.00K 10-Q · filed 2022-05-10 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 |